Clinical trial
Post Marketing Surveillance of Jyseleca Tab. (Filgotinib Maleate) in Korean Subjects
NCT06246123 is registered in ClinicalTrials.gov with Eisai Korea Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Marketing Surveillance of Jyseleca Tab. (Filgotinib Maleate) in Korean Subjects
- Lead sponsor
- Eisai Korea Inc.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 27, 2024
- Completion date
- July 30, 2027
- Enrollment
- 2,040 (estimated)
- Sites
- 59
Conditions
As the registry lists them; a condition with its own page is linked.